Why Tandem Diabetes Care Stock Popped Today

robot
Abstract generation in progress

Tandem Diabetes Care (NASDAQ: TNDM) experienced a significant stock increase of over 32% after reporting substantial gains in profitability for the fourth quarter. The company’s new pay-as-you-go pharmacy structure is driving margin expansion and recurring revenue, with gross margin improving to 58%. Management anticipates continued profitable growth and expects full-year sales for 2026 to be between $1.065 billion and $1.085 billion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)